CHICAGO TRUST Co NA Sells 5,295 Shares of Neogen Co. (NASDAQ:NEOG)

CHICAGO TRUST Co NA reduced its stake in Neogen Co. (NASDAQ:NEOG) by 33.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,498 shares of the company’s stock after selling 5,295 shares during the period. CHICAGO TRUST Co NA’s holdings in Neogen were worth $127,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of NEOG. Select Equity Group L.P. grew its stake in Neogen by 23.1% in the 2nd quarter. Select Equity Group L.P. now owns 15,530,439 shares of the company’s stock valued at $242,741,000 after buying an additional 2,914,893 shares during the last quarter. Conestoga Capital Advisors LLC grew its position in shares of Neogen by 24.5% in the third quarter. Conestoga Capital Advisors LLC now owns 8,706,224 shares of the company’s stock valued at $146,352,000 after purchasing an additional 1,711,238 shares during the last quarter. State Street Corp increased its stake in shares of Neogen by 3.1% during the third quarter. State Street Corp now owns 7,932,192 shares of the company’s stock worth $133,340,000 after purchasing an additional 236,762 shares during the period. Bamco Inc. NY lifted its holdings in Neogen by 1.4% during the 3rd quarter. Bamco Inc. NY now owns 7,303,115 shares of the company’s stock worth $122,765,000 after purchasing an additional 98,067 shares during the last quarter. Finally, Champlain Investment Partners LLC boosted its stake in Neogen by 10.7% in the 3rd quarter. Champlain Investment Partners LLC now owns 7,110,530 shares of the company’s stock valued at $119,528,000 after purchasing an additional 690,029 shares during the period. 96.73% of the stock is owned by institutional investors.

Neogen Trading Up 2.3 %

Shares of NASDAQ:NEOG opened at $12.64 on Tuesday. The business’s 50 day simple moving average is $13.47 and its 200 day simple moving average is $15.04. Neogen Co. has a 1 year low of $11.46 and a 1 year high of $18.58. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.41 and a quick ratio of 2.79. The company has a market capitalization of $2.74 billion, a P/E ratio of -114.91 and a beta of 1.23.

Neogen (NASDAQ:NEOG) last released its earnings results on Friday, January 10th. The company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.12. Neogen had a positive return on equity of 2.80% and a negative net margin of 2.58%. The firm had revenue of $231.30 million during the quarter, compared to the consensus estimate of $227.16 million. During the same period in the prior year, the company posted $0.11 EPS. The company’s revenue was up .7% compared to the same quarter last year. On average, research analysts anticipate that Neogen Co. will post 0.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

NEOG has been the subject of a number of research reports. Guggenheim initiated coverage on Neogen in a report on Thursday, December 19th. They set a “buy” rating and a $15.00 target price for the company. StockNews.com raised shares of Neogen to a “sell” rating in a research report on Monday, September 30th.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.